Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04260048 · ClinicalTrials.gov registry record
Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 101
- Enrollment target
NCT04260048 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 101 participants.
The verdict
NCT04260048 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study during which they will complete 5 in-person study visits.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-02-21 |
| Est. Completion | 2024-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04260048
The ClinicalTrials.gov registry entry for NCT04260048 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04260048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04260048 about?
NCT04260048 is a clinical study titled "Impact of Hypothalamic Gliosis on Appetite Regulation and Obesity Risk in Children". BEAM is a multi-site longitudinal cohort study of hypothalamic gliosis, central regulation of appetite and weight gain in children. Participants will be recruited from the community in the greater Seattle and greater Baltimore area. All participants will consent to enroll in the 24-month study durin...
What is the current status of trial NCT04260048?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2020-02-21. Estimated completion is 2024-05-30.
Who is sponsoring clinical trial NCT04260048?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.